Medtronic Implants First Patient in Study of Rechargeable Neurostimulation System

Medtronic announced that it has implanted the first patient in its study of the InterStim Micro system, a rechargeable sacral neurostimulation (SNS) system.

The study, which will enroll 160 participants across 40 sites in the U.S., Europe, Canada and Australia, is the first study of a rechargeable SNS device for neurostimulation treatment for overactive bladder.

The InterStim Micro is the world’s smallest rechargeable SNS device and has a lifespan of 15 years, Medtronic said.